跳至主要内容
临床试验/NCT06312488
NCT06312488已完成不适用

Point of Care Evaluation of Fibrinolysis in Sepsis

Policlinico Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年1月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Prevalence of impaired fibrinolysis

研究概览

简要总结

Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years
  • sepsis or septic shock
  • vasopressors required to maintain a MAP ≥ 65 mmHg despite adequate fluid resuscitation

排除标准

  • coagulation disorders
  • ECMO therapy
  • use of oral anticoagulant drugs

研究组 & 干预措施

Healthy volunteers

Other

干预措施: Clot Pro (Diagnostic Test)

Septic patients

Other

干预措施: Clot Pro (Diagnostic Test)

结局指标

主要结局

Prevalence of impaired fibrinolysis

时间窗: Lysis time at 30 minutes at enrollment and on day 1, 2, 3, and 7

Lysis time at 30 minutes longer than 97.5th percentile of the calculated reference range of the ClotPro® TPA test

次要结局

  • Correlation between impaired fibrinolysis and changes in coagulation standard tests(Measures are performed at enrollment and on day 1, 2, 3, and 7)
  • Correlation between impaired fibrinolysis and ICU lenght of stay(Through study completion, an average of 1 year)
  • Correlation between impaired fibrinolysis and inflammation markers(Measures are performed at enrollment and on day 1, 2, 3, and 7)
  • Correlation between impaired fibrinolysis and multiorgan failure(Measures are performed at enrollment and on day 1, 2, 3, and 7)
  • Correlation between impaired fibrinolysis and ICU mortality(From date of enrollment until date of ICU discharge or date of death from any cause, whichever comes first, assessed up to 1 year)

研究者

发起方
Policlinico Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mauro Panigada

Principal Investigator

Policlinico Hospital

研究点 (1)

Loading locations...

相似试验